Enhanced potency of cell-based therapy for ischemic tissue repair using an injectable bioactive epitope presenting nanofiber support matrix

Jörn Tongers, Matthew J. Webber, Erin E. Vaughan, Eduard Sleep, Marie Ange Renault, Jerome G. Roncalli, Ekaterina Klyachko, Tina Thorne, Yang Yu, Katja Theres Marquardt, Christine E. Kamide, Aiko Ito, Sol Misener, Meredith Millay, Ting Liu, Kentaro Jujo, Gangjian Qin, Douglas W. Losordo, Samuel I. Stupp, Raj Kishore

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The translation of cell-based therapies for ischemic tissue repair remains limited by several factors, including poor cell survival and limited target site retention. Advances in nanotechnology enable the development of specifically designed delivery matrices to address these limitations and thereby improve the efficacy of cell-based therapies. Given the relevance of integrin signaling for cellular homeostasis, we developed an injectable, bioactive peptide-based nanofiber matrix that presents an integrin-binding epitope derived from fibronectin, and evaluated its feasibility as a supportive artificial matrix for bone marrow-derived pro-angiogenic cells (BMPACs) used as a therapy in ischemic tissue repair. Incubation of BMPACs with these peptide nanofibers in vitro significantly attenuated apoptosis while enhancing proliferation and adhesion. Pro-angiogenic function was enhanced, as cells readily formed tubes. These effects were, in part, mediated via p38, and p44/p42 MAP kinases, which are downstream pathways of focal adhesion kinase. In a murine model of hind limb ischemia, an intramuscular injection of BMPACs within this bioactive peptide nanofiber matrix resulted in greater retention of cells, enhanced capillary density, increased limb perfusion, reduced necrosis/amputation, and preserved function of the ischemic limb compared to treatment with cells alone. This self-assembling, bioactive peptide nanofiber matrix presenting an integrin-binding domain of fibronectin improves regenerative efficacy of cell-based strategies in ischemic tissue by enhancing cell survival, retention, and reparative functions.

Original languageEnglish
Pages (from-to)231-239
Number of pages9
JournalJournal of Molecular and Cellular Cardiology
Volume74
DOIs
Publication statusPublished - Sep 2014

    Fingerprint

Keywords

  • Angiogenesis
  • Biomaterials
  • Cell therapy
  • Microcirculation
  • Nanomedicine
  • Regenerative medicine

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

Tongers, J., Webber, M. J., Vaughan, E. E., Sleep, E., Renault, M. A., Roncalli, J. G., Klyachko, E., Thorne, T., Yu, Y., Marquardt, K. T., Kamide, C. E., Ito, A., Misener, S., Millay, M., Liu, T., Jujo, K., Qin, G., Losordo, D. W., Stupp, S. I., & Kishore, R. (2014). Enhanced potency of cell-based therapy for ischemic tissue repair using an injectable bioactive epitope presenting nanofiber support matrix. Journal of Molecular and Cellular Cardiology, 74, 231-239. https://doi.org/10.1016/j.yjmcc.2014.05.017